Persister cancer cells were reported to be vulnerable to inhibition of GPx4, leading to enhanced lipid peroxidation and ferroptosis [93], thus suggesting the potential of targeting lipid peroxidation pathways to overcome drug resistance in cancer cells. Here, GPX4 is linked to cancer.